DNA and Gene Chip Market Size & Share, Sector / Industry Report & Analysis 2020, & Forecast 2021-2026 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Global DNA and Gene Chip Market


The global DNA and Gene Chip market size is projected to reach US$ 11.89 billion by 2026, from US$ 6.22 billion in 2020, at a CAGR of 11.4% during 2021-2026.The ability of DNA microarrays to allow comprehensive simultaneous analysis of thousands of genes has resulted in the success of this technology in the past decade. Technological advancements in computational capabilities, robotics, and fabrication methods for microarrays have led to rapid uptake of gene chips in clinical laboratories across the globe. Although the popularity of Next Generation Sequencing (NGS) has skyrocketed in the recent past, NGS is not yet able to completely replace microarrays in diagnostics and cytogenetics due to its relatively high price and steady rate of clinical implementation.

Absence of a well-structured and defined regulatory framework pertaining to use of NGS in clinics is one of the factors driving adoption of microarray methods over NGS protocols. Furthermore, less complicated and less labor-intensive steps for sample preparation in DNA gene chip has led to its widespread adoption among research groups and other life science entities.

Generation of massive DNA sequence information from the Human Genome Project and gene expression studies further pronounced the need for solutions to catalog this vast information into a usable form. This factor is one of the key forces behind extensive use of microarray technology in the past years. The technology has effectively proven its efficiency in accelerating clinical utility of genomic information available on public databases.

Advancements in DNA microarrays has resulted in an expansion of its application in biomedicine applications. Vendors are engaged in development of novel solutions for storage and analysis of microarray-generated data to facilitate biomedicine applications of array technology.

Research collaborations between companies and research communities is aiding the technology in gaining grounds in the field of genomics. For instance, in February 2016, Illumina, Inc. signed four biobanking agreements with University of Colorado, Montreal Heart Institute, Vanderbilt University, and Partners HealthCare. This collaboration was intended for the implementation of Illuminas array platform for genotyping of sample collected at research institutes.

Capability of gene chips in high-throughput monitoring of biomolecules has triggered significant applications in new areas of interest such as pharmacogenomics. This factor has prompted several pharmaceutical firms to adopt this tool for acceleration of drug development process.

Effective implementation of genomic chips for gene expression analysis has also encouraged the use of this tool in non-traditional research areas such as environmental science and agriculture. Agri-biotech companies and research institutes are making significant use of microarray technology for testing of genetically modified foods and crop improvement to overcome challenges of crop reproducibility.

However, this technology is experiencing high market competition from other throughput technologies such as next-generation sequencing. Plummeting costs of sequencing technologies owing to rapid advances in NGS is expected to majorly impede the future market for DNA gene chips. Applications such as chromatin immunoprecipitation and gene expression are witnessing higher adoption of NGS platforms over microarrays due to its cost-effectiveness, specificity, and accuracy.

Market Segmentation, Outlook & Viewpoint: Global DNA and Gene Chip Market

Application Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

  
Cancer Diagnosis & Treatment
  
Gene Expression
  
Genotyping
  
Genomics
  
Drug Discovery
  
Agricultural Biotechnology
  
Others

Product Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

  
Consumables
  
Instrumentation

End-use Market Segmentation & Outlook (Revenue, USD Million, 2014 - 2025)

  
Academic & Government Research Institutes
  
Hospitals & Diagnostics Centers
  
Biotechnology & Pharmaceutical Companies
  
Others

Key Players, Recent Developments & Regional Insights: Global DNA and Gene Chip Market

Consumables accounted for the largest share in the DNA & gene chip market in 2017 and the segment is expected to retain its dominance over the forecast period. This growth can be attributed to technological advancements in gene expression data analysis algorithms, coupled with easy availability of reagents and others ancillary components required for implementing a microarray procedure.

Instruments for microarrays are expected to witness substantial growth over the forecast period owing to introduction of new instruments for assistance in gene studies through microarray systems. For instance, in November 2016, Applied Micro Arrays announced its offering of Innopsys range of microarray scanners for research and diagnostic customers.

Application Insights

Cancer diagnosis and treatment accounted for the largest share owing to rising demand as well as popularity for targeted cancer therapies. Genetic chips provide a better picture of a patients cancer genomic profile, which further guides in selecting the appropriate cancer therapy.
On the other hand, drug discovery is expected to emerge as the fastest growing application segment as a consequence

of increasing adoption of genomic chip arrays for optimization of different aspects of traditional drug discovery processes such as disease pathway identification, disease pathway validation, compound screening, and clinical trials.

End-use Insights

The market has been segmented on the basis of end use into academic and government research institutes, hospitals and diagnostics centers, biotechnology and pharmaceutical companies, and others. Academic and government institutes accounted for the dominant share in the market in 2017 owing to accelerated uptake of DNA microarrays by researchers to conduct their research projects in a wide range of applications. The segment is also anticipated to register the highest growth rate over the course of the forecast period.

Hospitals and diagnostic centers accounted for the second-largest share in 2017. Fewer complexities pertaining to implementation of microarrays has enabled diagnostic developers to use this technology across various diagnostic aspects such as non-invasive prenatal testing (NIPT).

Regional Insights

The North America market captured the largest share owing to factors such as presence of well-established players, advanced informatics infrastructure, presence of experts and skilled workforce, and ongoing genomic R & D practices on a large scale in the region.

Asia Pacific is expected to emerge as a promising market, registering the highest CAGR over the forecast period as a result of rising R & D investments in genomic research. Moreover, growing awareness regarding genetic tests for disease risk assessment and prevention is anticipated to have a positive impact on the growth of the regional market.

DNA & Gene Chip Market Share Insights

Some of the major players in the market are Thermo Fisher Scientific, Inc. (Affymetrix, Inc.); Agilent Technologies; Illumina, Inc.; Perkin Elmer, Inc.; Arrayit Corporation; Macrogen Inc.; Asper Biotech; CapitalBio Corporation, Greiner Bio One International GmbH; Microarrays Inc.; MYcroarray; Oxford Gene Technology; TOSHIBA HOKUTO ELECTRONICS CORPORATION; Savyon Diagnostics; Applied Micro Arrays; and bioMerieux SA.

These entities are engaged in strategic partnerships with genetic labs and other life science companies to maintain their competitive edge in the market. For instance, in December 2014, Arrayit Corporation entered into a cooperative R & D agreement with the United States Department of Agriculture (USDA) for development of detection methods for bacterial and viral foodborne pathogens that include Salmonella, Campylobacter, Norovirus, hepatitis, Listeria, and E. coli. This development of detection technologies was based on Arrayits patented DNA microarray platform and USDAs DNA sequence detection method.

Key Insights Covered: Global DNA and Gene Chip Market

1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of DNA and Gene Chip industry.
2. Global major manufacturers" operating situation (sales, revenue, growth rate and gross margin) of DNA and Gene Chip industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of DNA and Gene Chip industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of DNA and Gene Chip industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of DNA and Gene Chip industry.

Research Methodology: Global DNA and Gene Chip Market

  
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other